Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Medicinal Plant Images

    Medicinal Plant Images

    wadmin2By wadmin2May 6, 2017Updated:August 12, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    I.E.Cock1,2*
    1School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, Australia.
    2Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, Australia.

    Pharmacognosy Communications,2017,7,2,102-103.
    Published: May 2017
    Type: Medicinal Plant Images

    ABSTRACT

    Strelitzia reginae Aiton (family Strelitziaceae), commonly known as bird of paradise and crane flower, is a perennial plant which is native to South Africa. The plant grows to 2 m tall, with large leaves to 70 cm long and 30 cm wide.The species produces showy flowers consisting of orange sepals and purple or blue petals and has been widely naturalised globally as an ornamental plant. However, S. reginae also is used in South African traditional medicine to treat diseases caused by bacterial pathogens, particularly urinary tract infections (UTI’s) and sexually transmitted infections (STI’s).1,2 Decoctions prepared from crushed S. reginae roots were considered particularly useful for the easing the symptoms of sexually transmitted diseases (including inflamed glands) in cultures from the Kwa Zulu-Natal region of South Africa, including the Zulus. A recent study screened a panel of South African plants with traditional uses in the treatment of STI’s and UTI’s for the ability to inhibit the pathogens Candida albicans (thrush), Gardnerella vaginalis (bacterial vaginosis), Neisseria gonorrhoeae (gonorrhea), Oligellaureolytica (bacterial vaginosis), Trichomonas vaginalis (trichomoniasis), and Ureaplasma urealyticum (bacterial vaginosis).3 That study reported S. reginae dichloromethane: methanol (1:1) extracts inhibited the growth of all of the pathogens screened. The extract was a particularly good inhibitor of O. ureolytica and T. vaginalis, with MIC values of 0.6 and 1 mg/mL respectively. The extract was also a moderate inhibitor of C. albicans (2 mg/mL), G. vaginalis (3 mg/mL), Neisseria gonorrhoeae (2 mg/mL) and U. urealyticum (2 mg/mL). Interestingly, aqueous extracts (the form in which the plant is traditionally used) were generally substantially less potent, with MIC values up to 8 times higher than for the solvent extraction. This photograph was taken in Brisbane, Australia in 2016 by Dr Ian Cock. Read more…

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up